US2020253911A1PendingUtilityA1
Method of treating renal system damage
Assignee: THE UNIV OF UTAH RESEARCH FOUNDATIONPriority: Jun 19, 2008Filed: Jan 27, 2020Published: Aug 13, 2020
Est. expiryJun 19, 2028(~1.9 yrs left)· nominal 20-yr term from priority
Inventors:Tianxin Yang
A61K 31/201A61K 31/704A61K 31/231A61K 45/06
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of treating the side effects of a toxic medical therapy using nitrated lipids are disclosed herein. In particular, the methods comprise the use of nitrated fatty acids or esters thereof to treat side effects, including organ system damage, caused by chemotherapy, radiotherapy, and the administration of other toxic agents.
Claims
exact text as granted — not AI-modified1 . A method of treating renal system damage in a subject, comprising:
orally administering to the subject an effective amount of a nitrated fatty acid, wherein the renal system damage is selected from a group consisting of nephrotoxicity, distortion of the overall renal morphology, dilation of renal tubules, appearance of protein cast, oxidative stress, necrosis, and apoptosis of organ cells.
2 . The method of claim 1 , wherein the nitrated fatty acid is a monosaturated fatty acid or a polyunsaturated fatty acid.
3 . The method of claim 2 , wherein the nitrated fatty acid is nitro-oleic acid.
4 . The method of claim 3 , wherein the nitrated fatty acid is selected from the group consisting of 9-nitrooelic acid, 10-nitrooleic acid, and combinations thereof.
5 . The method of claim 4 , wherein the nitrated fatty acid is 9-nitrooelic acid.
6 . The method of claim 4 , wherein the nitrated fatty acid is 10-nitrooleic acid.
7 . The method of claim 5 , wherein the effective amount is from about 1 milligram per day to about 500 milligrams per day.
8 . The method of claim 6 , wherein the effective amount is from about 1 milligram per day to about 500 milligrams per day.
9 . The method of claim 1 , wherein the renal system damage is nephrotoxicity.
10 . The method of claim 1 , wherein the renal system damage is distortion of the overall renal morphology.
11 . The method of claim 1 , wherein the renal system damage is dilation of renal tubules.
12 . The method of claim 1 , wherein the renal system damage is appearance of protein cast.
13 . The method of claim 1 , wherein the renal system damage is oxidative stress.
14 . The method of claim 1 , wherein the renal system damage is necrosis.
15 . The method of claim 1 , wherein the renal system damage is apoptosis of organ cells.Join the waitlist — get patent alerts
Track US2020253911A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.